Concepedia

Beth Apsel

BA

7

Publications

1.8K

Citations

7

H-Index

2003

Active since

Affiliations

University of California, San Francisco(Current)

Howard Hughes Medical Institute

University of California, Berkeley

New York University

Beth Apsel is an author at University of California, San Francisco specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyChemical BiologyNatural SciencesMolecular BiologyBiomolecular EngineeringGeneticsBiochemistry

Publications per year

2003–2009

7

Publications

7

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

Morris E. Feldman, Beth Apsel, Aino Uotila et al. · PLoS Biology · 2009 · 1.1K citations · Full text

Drug Target, Mrna Translation, Molecular Biology +24

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases

Beth Apsel, Jimmy A. Blair, Beatriz González et al. · Nature Chemical Biology · 2008 · 436 citations · Full text

Drug Target, Drug Targeting, Biochemistry +10

Discovery of Trypanocidal Compounds by Whole Cell HTS of <i>Trypanosoma brucei</i>

Zachary B. Mackey, Arthur M. Baca, Jeremy P. Mallari et al. · Chemical Biology & Drug Design · 2006 · 106 citations · Full text

Discovery of Drug-Resistant and Drug-Sensitizing Mutations in the Oncogenic PI3K Isoform p110α

Eli R. Zunder, Zachary A. Knight, Benjamin T. Houseman et al. · Cancer Cell · 2008 · 96 citations · Full text

Oncogenic Agent, Genetics, Molecular Biology +5

Cyclooxygenase-2-Derived E Prostaglandins Down-Regulate Matrix Metalloproteinase-1 Expression in Fibroblast-Like Synoviocytes via Inhibition of Extracellular Signal-Regulated Kinase Activation

Michael H. Pillinger, Sonia Tolani, Beth Apsel et al. · The Journal of Immunology · 2003 · 76 citations · Full text

Rows per page

1–5 of 7